1.7.4 Oncogenic Activation Definition

Oncogenic Activation Definition is the description of the general process, encompassing any of several distinct molecular mechanisms, by which a normal cellular gene or its protein product acquires an abnormally elevated or unregulated level of growth-promoting activity, resulting in a contribution to cancerous cell behavior. Oncogenic activation serves as the broad conceptual umbrella beneath which the specific mechanisms of mutation, amplification, chromosomal rearrangement, and epigenetic dysregulation are each understood as particular routes to the same overall outcome, namely the conversion of a normally regulated growth-promoting function into one that operates inappropriately.

Conceptual Basis of Oncogenic Activation

A Unifying Functional Concept

Oncogenic activation describes a functional outcome rather than any single molecular event, uniting a variety of distinct mechanisms under the shared criterion that each results in abnormally increased or abnormally unrestrained growth-promoting activity, regardless of whether that increase arises from a structural change to a protein, an increase in gene copy number, a change in gene regulatory context, or a change in epigenetic state.

Distinction From Loss-of-Function Alteration

Oncogenic activation is defined in direct contrast to the loss-of-function alterations that inactivate genes which would otherwise restrain cellular growth, since oncogenic activation specifically involves a gain or amplification of an existing growth-promoting function rather than the elimination of a growth-restraining one.

Categories of Mechanism Producing Oncogenic Activation

Activation Through Structural Alteration of the Encoded Protein

Oncogenic activation can occur when a mutation alters the structure of the protein encoded by a growth-promoting gene, producing a version of that protein that remains active independent of the upstream signal that would normally be required to trigger its function.

Activation Through Increased Gene Dosage

Oncogenic activation can occur when the number of copies of a growth-promoting gene present within the cell's genome is increased, resulting in production of a greater total quantity of that gene's protein product and a correspondingly amplified growth-promoting signal, even though each individual copy of the protein remains structurally normal.

Activation Through Altered Regulatory Context

Oncogenic activation can occur when a growth-promoting gene is repositioned, through chromosomal rearrangement, into a new regulatory context that drives its expression at an inappropriate level, at an inappropriate time, or within a cell type in which it would not normally be expressed.

Activation Through Epigenetic Dysregulation

Oncogenic activation can occur when the epigenetic marks normally maintaining a growth-promoting gene in a silenced or low-expression state are removed, resulting in inappropriate transcriptional activation of that gene without any accompanying change to its coding sequence.

Common Downstream Consequences of Oncogenic Activation

Engagement of Growth-Promoting Signaling Pathways

Regardless of the specific mechanism involved, oncogenic activation typically results in inappropriate engagement of the intracellular signaling pathways responsible for promoting cell growth, division, or survival, producing a downstream cellular response that would normally occur only in the presence of an appropriate external growth signal.

Independence From Normal Regulatory Constraints

A common thread among the various mechanisms of oncogenic activation is that the resulting abnormal signal becomes at least partially independent of the regulatory constraints that would normally govern the corresponding unaltered gene, allowing the growth-promoting activity to persist even under conditions that would normally suppress it.

Significance of Oncogenic Activation Within Cancer Cell Biology

A Framework for Classifying Diverse Molecular Events

The concept of oncogenic activation provides a unifying framework for classifying the diverse molecular events observed across different cancers and different genes as instances of a shared underlying phenomenon, allowing findings from the study of one activating mechanism to inform the understanding of functionally analogous mechanisms affecting different genes.